MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows MilliporeSigma to offer full range of bioreactors, from 2ml to 2000L Adds to company’s expertise in monoclonal antibody (mAb) process development Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading [...]

Thermo Fisher Scientific Raises Greenhouse Gas Emissions Reduction Target on Path to Net-zero Emissions

Company to achieve 2030 Scope 1 and 2 greenhouse gas emissions reduction target of 30% ahead of schedule; increases ambition to 50% reduction, aligned with 1.5˚C pathway WALTHAM, Mass. --  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a new 2030 greenhouse gas emissions reduction target to reduce its [...]

Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels

Assays can detect more than 90 different disease pathogens CARLSBAD, Calif. -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TrueMark Infectious Disease Research Panels designed to enable rapid and accurate detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. To [...]

NanoString Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform

Products Represent the Highest Plex In Situ Imager and the First Cloud-Based Data Analysis Suite for Spatial Biology SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first commercial shipment of the CosMx™ Spatial Molecular Imager (SMI) and the AtoMx™ Spatial Informatics [...]

Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce

First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening Acquisition strengthens Molecular Devices’ position as a 3D biology solutions innovator Combined expertise will accelerate industry adoption of physiologically-relevant cell models for drug discovery SAN JOSE, Calif., and CARDIFF, Wales – Molecular Devices, LLC., a leading provider of high-performance life science solutions, [...]

Grenova Earns ISO 9001:2015 and ISO 13485:2016 Certification as Part of Its Mission to Manufacture Green Technology that Makes Laboratories More Sustainable

RICHMOND, Va. -- Grenova, creator of the laboratory industry's only patented technology for washing and reusing plastic consumables, announced today that it has earned ISO 9001:2015 and ISO 13485:2016 certification as part of the company's mission to make laboratories around the world sustainable, resilient, cost-effective, and highly efficient. The International Organization for Standardization (ISO) develops and publishes [...]

Congenica awarded second stage of European contract to develop NGS analysis workflow in oncology

CAMBRIDGE, England -- Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has been awarded the second stage of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology for a group of seven Central European hospitals represented by the Medical University Graz. The European Union Horizon [...]

Pierian Selected by PreCheck Health Services to Support Hereditary Cancer Testing for Providers and Patients

Pierian®, a global leader in advanced clinical genomics technology and services, announced a collaboration to support PreCheck Health Services, a CLIA-registered, CAP-accredited high complexity laboratory, in providing cancer-related genomic testing programs for medical practices and patients in addition to the launch of an in-house next-generation sequencing (NGS) program. Read our full press release by clicking [...]

Biognosys Launches New Version of Spectronaut® at HUPO International Proteomics Congress

Spectronaut 17 features directDIA+™, the best-performing library-free workflow for DIA proteomics available on the market ZURICH & CANCUN, Quintana Roo, Mexico — Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch Spectronaut 17 today at the HUPO 2022 World Congress in Cancun, Mexico. Since its first release in 2003, Spectronaut has continuously [...]

BUCHI Ibérica to serve Spain and Portugal

As of January 2023, Barcelona-based BUCHI Ibérica will take over the Portuguese market. The entire Iberian Peninsula will be handled exclusively by the BUCHI Group. An important milestone in the development of the Iberian market organization, which was only founded in 2021. After 20 years of successful cooperation, the previous main Portuguese distribution partner Rotoquimica [...]

Access IBO on Knowledge Center
Register to Subscribe Login for Access


Register to Subscribe Login for Access

Lost your password? Register